ALXN
Alexion Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2021
- #364
- Final score
- 52.22
- Years on list
- 2
↗ Climbed 114 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- ALXN
- RPRX· Royalty Pharma Plc
- CTLT· Catalent, Inc.
Figure 01 · Side-by-side summary
The headline numbers
RPRX
Royalty Pharma PlcPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #672
- Final score
- 42.76
- Years on list
- 5
↘ Down 321 since 2021
CTLT
Catalent, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2024
- #389
- Final score
- 52.86
- Years on list
- 5
↘ Down 22 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | ALXN | RPRX | CTLT |
|---|---|---|---|
| Climate Change | — | 41.2 | — |
| Employee Relations | — | 44.0 | — |
| Environment | — | 31.2 | — |
| Stakeholders & Society | — | 45.3 | — |
| Human Rights | — | 45.4 | — |
| Governance | — | 42.6 | — |
| Performance Rating | — | 79.4 | — |